RSPH vs. MHIP
RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and MHIP (Milliman Healthcare Inflation Plus ETF) are both Health & Biotech Equities funds. RSPH is passively managed, while MHIP is actively managed. A 0.73 correlation means they provide meaningful diversification when combined. RSPH charges 0.40%/yr vs 0.55%/yr for MHIP.
Performance
RSPH vs. MHIP - Performance Comparison
Loading charts...
Returns By Period
RSPH
- 1D
- 0.35%
- 1M
- 6.24%
- 6M
- 3.99%
- YTD
- 7.48%
- 1Y
- 18.40%
- 3Y*
- 5.25%
- 5Y*
- 3.49%
- 10Y*
- 8.80%
MHIP
- 1D
- -0.57%
- 1M
- 1.53%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
RSPH vs. MHIP - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
RSPH Invesco S&P 500 Equal Weight Health Care ETF | 9.27% |
MHIP Milliman Healthcare Inflation Plus ETF | 0.13% |
Correlation
The correlation between RSPH and MHIP is 0.73, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Apr 21, 2026 | 0.73 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RSPH vs. MHIP — Risk / Return Rank
RSPH
MHIP
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
RSPH vs. MHIP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P 500 Equal Weight Health Care ETF (RSPH) and Milliman Healthcare Inflation Plus ETF (MHIP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RSPH | MHIP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.21 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.70 | — | — |
| Martin ratioReturn relative to average drawdown | 4.27 | — | — |
Loading charts...
Drawdowns
RSPH vs. MHIP - Drawdown Comparison
The maximum RSPH drawdown since its inception was -40.49%, which is greater than MHIP's maximum drawdown of -3.09%. Use the drawdown chart below to compare losses from any high point for RSPH and MHIP.
Loading charts...
Drawdown Indicators
| RSPH | MHIP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.49% | -3.09% | -37.40% |
Max Drawdown (1Y)Largest decline over 1 year | -10.87% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -17.13% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -21.95% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -30.44% | — | — |
Current DrawdownCurrent decline from peak | -1.22% | -1.48% | +0.26% |
Average DrawdownAverage peak-to-trough decline | -6.12% | -1.25% | -4.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.33% | — | — |
Volatility
RSPH vs. MHIP - Volatility Comparison
Loading charts...
Volatility by Period
| RSPH | MHIP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.28% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 11.47% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 16.26% | 11.73% | +4.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.46% | 11.73% | +4.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.74% | 11.73% | +6.01% |
RSPH vs. MHIP - Expense Ratio Comparison
RSPH has a 0.40% expense ratio, which is lower than MHIP's 0.55% expense ratio.
Dividends
RSPH vs. MHIP - Dividend Comparison
RSPH's dividend yield for the trailing twelve months is around 0.68%, while MHIP has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MHIP Milliman Healthcare Inflation Plus ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RSPH Invesco S&P 500 Equal Weight Health Care ETF | 0.68% | 0.70% | 0.71% | 0.66% | 0.64% | 0.50% | 0.51% | 0.54% | 0.53% | 0.47% | 0.48% | 0.49% |
Frequently Asked Questions
RSPH and MHIP have a correlation of 0.73, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, RSPH is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
RSPH is cheaper with a 0.40% expense ratio, compared with 0.55% for MHIP.
RSPH has the higher dividend yield at 0.68%, compared with 0.00% for MHIP.
They also come from different issuers: Invesco and Milliman. Their fees differ too: 0.40% for RSPH and 0.55% for MHIP.
Find the right allocation for RSPH and MHIP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer